Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial

Walgreens Boots Alliance (WBA) Stock Price, News & Analysis

$9.21
+0.18 (+1.99%)
(As of 10/11/2024 ET)

About Walgreens Boots Alliance Stock (NASDAQ:WBA)

Key Stats

Today's Range
$8.81
$9.28
50-Day Range
$8.25
$11.48
52-Week Range
$8.22
$27.05
Volume
19.81 million shs
Average Volume
16.44 million shs
Market Capitalization
$7.95 billion
P/E Ratio
N/A
Dividend Yield
10.86%
Price Target
$13.46
Consensus Rating
Reduce

Company Overview

Walgreens Boots Alliance Inc. is a world-renowned healthcare, pharmacy, and retailing company. Founded in 1901 by John Boot and Charles R. Walgreen, the company has grown to become a leader in the industry, operating in nine countries and providing access to healthcare services to millions of people around the world. Walgreens Boots Alliance operates through three main segments: U.S. Retail Pharmacy, International, and U.S. Healthcare.

The U.S. Retail Pharmacy segment includes the Walgreens business, which operates health and wellness services, retail drugstores, specialty and home delivery pharmacy services, and an equity method investment in AmerisourceBergen. Walgreens stores have locations in all 50 U.S. states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands, offering access to consumer goods and services, pharmacy, photo department, and health and wellness services. Walgreens also operates online stores like Walgreens.com, Drugstore.com, VisionDirect.com, and Beauty.com.

The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution company in Germany. This segment includes the Boots brand, which has a history stretching back over 170 years in the United Kingdom, and stores in Ireland and Thailand with Boots franchise operations in the Middle East and Indonesia. The remainder of the division comprises Farmacias Ahumada (FASA) pharmacies in Chile and Benavides in Mexico. The Pharmaceutical Wholesale Division, including the Alliance Healthcare brand, supplied medicines and other healthcare products to more than 115,000  doctors, health centers,  pharmacies, and hospitals annually in eleven countries through 306 distribution centers. AmerisourceBergen purchased most of the Alliance Healthcare wholesale division in June 2021 for $6.275bn in cash.

The U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omnichannel experience across the care journey. This segment includes the operation of 334 VillageMD clinics, including 146 co-located clinics, 124 standalone clinics, and 64 affiliate clinics.

Walgreens Boots Alliance produces many brands, including Soltan and Botanics, Boots Pharmaceuticals, and Boots Laboratories, No. 7, that Alliance Boots and Walgreens sought to launch internationally following the first share purchase in 2012. These brands include the famous No. 7 beauty serums, developed in Nottingham, the UVA 5-star suncare protection by Soltan, and the Botanics range, developed in partnership with the Royal Botanic Gardens, Kew. Boots' brand range includes medicines, healthcare products, skincare, and many more. Walgreens also has a self-branded line of products called "Well at Walgreens."

For the fiscal year 2020, Walgreens Boots Alliance reported earnings of US$456 million. The reported revenue was US$139.5 billion, an increase of 2.5% over the previous fiscal cycle. As of 2022, Walgreens Boots Alliance is ranked #18 on the Fortune 500 rankings. The company pays a Quarterly dividend of $0.48, representing an annual dividend yield of 5.08%. Wall Street analysts consider Walgreens stock to be Undervalued. 

Walgreens Boots Alliance has 862,503,540 shares outstanding, and its market cap is currently $31.99B. The company’s EPS estimate is $1.12, and its most recent earnings report saw it beat expectations with an EPS of $1.16. Following the earnings report, the stock price went down -6.135%. Among the most significant hedge funds holding Walgreens Boots Alliance’s shares is Antipodes Partners Ltd., which owns shares valued at $58M.

Walgreens Boots Alliance is a global healthcare leader committed to providing high-quality services and products to its customers. The company’s innovative strategies have earned it a reputation as a reliable and reputable partner for healthcare providers and consumers. With its wide array of products and services, Walgreens Boots Alliance is well-positioned to continue growing and meeting the needs of its customers for years to come.

Walgreens Boots Alliance Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
89th Percentile Overall Score

WBA MarketRank™: 

Walgreens Boots Alliance scored higher than 89% of companies evaluated by MarketBeat, and ranked 60th out of 216 stocks in the retail/wholesale sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Walgreens Boots Alliance has received a consensus rating of Reduce. The company's average rating score is 1.86, and is based on 2 buy ratings, 8 hold ratings, and 4 sell ratings.

  • Amount of Analyst Coverage

    Walgreens Boots Alliance has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Walgreens Boots Alliance's stock forecast and price target.
  • Earnings Growth

    Earnings for Walgreens Boots Alliance are expected to decrease by -39.51% in the coming year, from $2.86 to $1.73 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Walgreens Boots Alliance is -1.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Walgreens Boots Alliance is -1.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Walgreens Boots Alliance has a PEG Ratio of 1.03. PEG Ratios around 1 indicate that a company is correctly valued.

  • Price to Book Value per Share Ratio

    Walgreens Boots Alliance has a P/B Ratio of 0.28. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Walgreens Boots Alliance's valuation and earnings.
  • Percentage of Shares Shorted

    13.30% of the float of Walgreens Boots Alliance has been sold short.
  • Short Interest Ratio / Days to Cover

    Walgreens Boots Alliance has a short interest ratio ("days to cover") of 4.9.
  • Change versus previous month

    Short interest in Walgreens Boots Alliance has recently increased by 5.68%, indicating that investor sentiment is decreasing significantly.
  • Dividend Leadership

    Walgreens Boots Alliance is a leading dividend payer. It pays a dividend yield of 11.22%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Walgreens Boots Alliance does not have a long track record of dividend growth.

  • Dividend Sustainability

    Based on earnings estimates, Walgreens Boots Alliance will have a dividend payout ratio of 57.80% next year. This indicates that Walgreens Boots Alliance will be able to sustain or increase its dividend.

  • Read more about Walgreens Boots Alliance's dividend.
  • Percentage of Shares Shorted

    13.30% of the float of Walgreens Boots Alliance has been sold short.
  • Short Interest Ratio / Days to Cover

    Walgreens Boots Alliance has a short interest ratio ("days to cover") of 4.9.
  • Change versus previous month

    Short interest in Walgreens Boots Alliance has recently increased by 5.68%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Walgreens Boots Alliance has a news sentiment score of 0.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.65 average news sentiment score of Retail/Wholesale companies.
  • News Coverage This Week

    MarketBeat has tracked 23 news articles for Walgreens Boots Alliance this week, compared to 22 articles on an average week.
  • Search Interest

    Only 94 people have searched for WBA on MarketBeat in the last 30 days. This is a decrease of -31% compared to the previous 30 days.
  • MarketBeat Follows

    48 people have added Walgreens Boots Alliance to their MarketBeat watchlist in the last 30 days. This is an increase of 33% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Walgreens Boots Alliance insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    17.40% of the stock of Walgreens Boots Alliance is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    58.59% of the stock of Walgreens Boots Alliance is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Walgreens Boots Alliance's insider trading history.

WBA Stock News Headlines

Food delivery during coronavirus outbreak. Paper bag with grocery order in front of the door in Paris, France during Covid-19 epidemic. Safe online shopping, food donation or takeout meal concept
Instacart Is Revolutionizing Groceries: Why It's Time to Invest (WBA)
It can be confusing, but Maplebear Inc. (NASDAQ: CART) is better known as Instacart, the world's largest online grocery marketplace.
Financial markets news icon
5 Oversold Stocks to Buy Right Now (WBA)
We've got you covered with a list of oversold stocks to buy right now. Learn more about oversold and overbought stocks on MarketBeat.
Case study on my NKE trade
Now, I won’t lie, I’m pretty stinkin’ proud of my track record trading Gamma Pockets… After all, I thought I’d retired to a quiet life as a stay-at-home dad… my days at PIMCO were long behind me… But, after seeing this track record, Roger insisted I come out of retirement and share these trades with the world. So I’m gonna do that on Monday. At 1pm ET, Roger and I will finally share the Gamma Pockets Summit!
A Walgreens store in Bradenton, Fla., is shown on February 9, 2024. (AP Photo/Gene J. Puskar, File)
Walgreens to pay $106M to settle allegations it submitted false payment claims for prescriptions
Walgreens agreed to pay $106 million to settle lawsuits that alleged it submitted false payment claims with government health care programs for prescriptions that were never dispensed
Should You Buy the 3 Highest Yielding S&P Stocks?
Barclays Remains a Sell on Walgreens Boots Alliance (WBA)
See More Headlines

WBA Stock Analysis - Frequently Asked Questions

Walgreens Boots Alliance's stock was trading at $26.11 at the beginning of the year. Since then, WBA stock has decreased by 64.7% and is now trading at $9.21.
View the best growth stocks for 2024 here
.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) posted its quarterly earnings results on Thursday, June, 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing analysts' consensus estimates of $0.68 by $0.05. The firm's revenue was up 2.8% compared to the same quarter last year.
Read the conference call transcript
.

Walgreens Boots Alliance subsidiaries include these companies: Shields Health Solutions, Innovation Associates Inc, Sinopharm Holding GuoDa Drug Store Co., Liz Earle Beauty, Take Care Health Employer Solutions, Alliance Boots Holdings Limited, Alliance Healthcare Deutschland AG, and more.

Top institutional investors of Walgreens Boots Alliance include Sound Income Strategies LLC (0.06%), Sanders Morris Harris LLC (0.02%), Czech National Bank (0.02%) and Czech National Bank (0.02%). Insiders that own company stock include Walgreens Boots Alliance, Inc, Timothy C Wentworth, Rosalind G Brewer, Manmohan Mahajan, Richard P Gates, John Patrick Driscoll, Kevin M Ban, Valerie B Jarrett, Inderpal S Bhandari and Nancy M Schlichting.
View institutional ownership trends
.

Shares of WBA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Walgreens Boots Alliance investors own include JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Symbotic (SYM), Verizon Communications (VZ), Meta Platforms (META), NVIDIA (NVDA), Intel (INTC) and Humana (HUM).

Company Calendar

Last Earnings
6/27/2024
Ex-Dividend for 9/12 Dividend
8/21/2024
Dividend Payable
9/12/2024
Today
10/11/2024
Next Earnings (Confirmed)
10/15/2024
Fiscal Year End
8/31/2025

Industry, Sector and Symbol

Industry
Drug stores & proprietary stores
Sub-Industry
Drug Retail
Current Symbol
NASDAQ:WBA
CUSIP
93142210
Employees
331,000
Year Founded
2014

Price Target and Rating

Average Stock Price Target
$13.46
High Stock Price Target
$22.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+47.0%
Consensus Rating
Reduce
Rating Score (0-4)
1.86
Research Coverage
14 Analysts

Profitability

Net Income
$-3,080,000,000.00
Pretax Margin
-9.34%

Debt

Sales & Book Value

Annual Sales
$139.08 billion
Cash Flow
$6.87 per share
Book Value
$32.78 per share

Miscellaneous

Free Float
713,065,000
Market Cap
$8.00 billion
Optionable
Optionable
Beta
0.70

Social Links


This page (NASDAQ:WBA) was last updated on 10/11/2024 by MarketBeat.com Staff
From Our Partners